NIBEC Co., Ltd. (KOSDAQ: 138610)

South Korea flag South Korea · Delayed Price · Currency is KRW
16,210
-740 (-4.37%)
Dec 20, 2024, 9:00 AM KST
-22.63%
Market Cap 176.58B
Revenue (ttm) 22.81B
Net Income (ttm) -7.85B
Shares Out 10.89M
EPS (ttm) n/a
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 264,611
Open 16,900
Previous Close 16,950
Day's Range 16,200 - 17,200
52-Week Range 13,740 - 25,850
Beta n/a
Analysts n/a
Price Target n/a
Earnings Date n/a

About NIBEC

NIBEC Co., Ltd., a healthcare company, engages in the manufacture and sale of dental bone grafts and tissue regenerative collagen products in South Korea and internationally. It offers dental ointment, peptide containing dental bone graft materials, regenerative biomaterials, tooth whitening, tooth desensitizer, herbal toothpaste, and cosmetic products. The company was founded in 2000 and is headquartered in Jincheon-gun, South Korea. [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2000
Employees 35
Stock Exchange KOSDAQ
Ticker Symbol 138610
Full Company Profile

Financial Performance

In 2023, NIBEC's revenue was 15.70 billion, a decrease of -27.53% compared to the previous year's 21.67 billion. Losses were -6.28 billion, 66.9% more than in 2022.

Financial Statements

News

There is no news available yet.